Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - INTEREST INCOME & EXPENSE
Interest Income & Expense RPRX - Royalty Pharma plc
226 M
LAST VALUE
9.65%
2 YEAR CAGR
-3.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR